scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1030726755 |
P356 | DOI | 10.1186/1471-2474-15-253 |
P932 | PMC publication ID | 4115216 |
P698 | PubMed publication ID | 25059987 |
P5875 | ResearchGate publication ID | 264245994 |
P2093 | author name string | Jun Zhou | |
Bing Wang | |||
Li-Ping Wang | |||
Xuan Feng | |||
Wei-Jin Zang | |||
Xiao-Lian Shi | |||
Dan-Dan Fan | |||
P2860 | cites work | Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials | Q28213612 |
Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
Modulation of T cell function by combination of epitope specific and low dose anticytokine therapy controls autoimmune arthritis | Q33267344 | ||
Angiogenesis and its targeting in rheumatoid arthritis | Q34051950 | ||
Huo-Luo-Xiao-Ling Dan modulates antigen-directed immune response in adjuvant-induced inflammation. | Q34077846 | ||
Immunological mechanisms involved in experimental peptide immunotherapy of T-cell-mediated diseases | Q34276518 | ||
Immunomodulation of Autoimmune Arthritis by Herbal CAM | Q34460609 | ||
Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond | Q34940456 | ||
Th17 cells in human disease. | Q35820734 | ||
Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis | Q36084456 | ||
Joint inflammation and cytokine inhibition in rheumatoid arthritis | Q36426881 | ||
Coxibs and heart disease: what we have learned and what else we need to know | Q36701215 | ||
TNF inhibition for ophthalmic indications: current status and outlook | Q38097327 | ||
Gene expression profiling in peripheral blood cells of patients with rheumatoid arthritis in response to anti-TNF-alpha treatments | Q38337833 | ||
Influence of interleukin-4 gene polymorphisms and interleukin-4 serum level on susceptibility and severity of rheumatoid arthritis in Egyptian population | Q39089824 | ||
RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines | Q39207905 | ||
Green tea protects rats against autoimmune arthritis by modulating disease-related immune events | Q42033670 | ||
The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis | Q42723170 | ||
Inhibition of adjuvant-induced arthritis by interleukin-10-driven regulatory cells induced via nasal administration of a peptide analog of an arthritis-related heat-shock protein 60 T cell epitope | Q44068971 | ||
Restriction of de novo pyrimidine biosynthesis inhibits Th1 cell activation and promotes Th2 cell differentiation | Q44129543 | ||
Prediction of functional impairment and remission in rheumatoid arthritis patients by biochemical variables and genetic polymorphisms | Q45070010 | ||
Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. | Q53163526 | ||
Inhibitors of p38 suppress cytokine production in rheumatoid arthritis synovial membranes: does variable inhibition of interleukin-6 production limit effectiveness in vivo? | Q54665731 | ||
Suppression of adjuvant arthritis in rats by induction of oral tolerance to mycobacterial 65-kDa heat shock protein | Q71785378 | ||
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis | Q78619454 | ||
T cells against the pathogenic and protective epitopes of heat-shock protein 65 are crossreactive and display functional similarity: novel aspect of regulation of autoimmune arthritis | Q81442959 | ||
Synthetic peptides from heat-shock protein 65 inhibit proinflammatory cytokine secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients | Q86500693 | ||
P304 | page(s) | 253 | |
P577 | publication date | 2014-07-25 | |
P1433 | published in | BMC Musculoskeletal Disorders | Q15751716 |
P1476 | title | Inhibition of adjuvant-induced arthritis by nasal administration of novel synthetic peptides from heat shock protein 65. | |
P478 | volume | 15 |
Q39242393 | Heat shock proteins and kidney disease: perspectives of HSP therapy |
Q38895446 | Heat shock proteins and their immunomodulatory role in inflammatory arthritis |
Q91652147 | Peptide-Based Vaccination Therapy for Rheumatic Diseases |
Q52801678 | Preparation and evaluation of biopolymeric nanoparticles as drug delivery system in effective treatment of rheumatoid arthritis. |
Q55340368 | Serum heat-shock protein-65 antibody levels are elevated but not associated with disease activity in patients with rheumatoid arthritis and ankylosing spondylitis. |
Search more.